You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
San Francisco Otolaryngology hopes that 2bPrecise's PGx technology can help manage the medication burden on older patients and improve symptoms of dementia.
In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.
Researchers identified one germline variant near TET2 that appears to be specific to individuals of African ancestry.
In Science this week: somatic mutation heterogeneity among human bladder samples, and more.
With targeted, exome, and whole-genome sequencing data, investigators saw recurrent driver mutations and heterogeneous mutational signatures in seemingly normal bladders.
The Oslo-based company plans to develop a test that can identify high-risk individuals based on an epigenetic signature.
Spun out of Insilico Medicine in January, Deep Longevity is developing artificial intelligence-based systems to track aging based on various biomarkers.
Dogs age more rapidly in their early years but then age more slowly later on, a DNA methylome analysis found, changing how dogs' ages are translated to human ages.
Study subjects of both sexes who had low germline mutation rates lived nearly five years longer than individuals with high mutation rates.
In Genome Research this week: target-mismatched sgRNA in microbial genome editing, strategy to examine gene expression throughout the cell cycle, and more.
Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.
The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.
The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.
In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.